[JAGX] Jaguar Animal Health, Inc.


Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 0.65 Change: -0 (-0.03%)
Ext. hours: Change: 0 (0%)

chart JAGX

Refresh chart

Strongest Trends Summary For JAGX

JAGX is in the medium-term down -31% in 2 months and up 2825% in 8 months.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities1.24 M Cash From Investing Activities Cash From Operating Activities-1.34 M Gross Profit30 K
Net Profit-3.94 M Operating Profit-2.68 M Total Assets4.84 M Total Current Assets3.98 M
Total Current Liabilities9.21 M Total Debt1.7 M Total Liabilities9.21 M Total Revenue60 K
Technical Data
High 52 week32.55 Low 52 week0.18 Last close14.91 Last change25.15%
RSI49.8 Average true range13.64 Beta1.11 Volume137.04 K
Simple moving average 20 days3.38% Simple moving average 50 days-12.24% Simple moving average 200 days106.3%
Performance Data
Performance Week18.33% Performance Month-14.42% Performance Quart-10.88% Performance Half3072.34%
Performance Year553.95% Performance Year-to-date6416.61% Volatility daily5.97% Volatility weekly13.35%
Volatility monthly27.37% Volatility yearly94.81% Relative Volume56.92% Average Volume7.95 M
New High New Low-0.02%


2019-06-18 08:00:00 | Jaguar Health Announces Completion of Pilot Study in Dogs in Support of Future Clinical Investigations Evaluating Crofelemer for Treatment of Noninfectious Diarrhea in Human Cancer Patients Receiving Tyrosine Kinase Inhibitors

2019-06-11 08:00:00 | Jaguar Health Subsidiary Receiving Preclinical Services Funded by the National Institute of Allergy and Infectious Diseases in Support of Development of Lechlemer Drug Product Candidate for Cholera Indication

2019-06-06 08:00:00 | Jaguar Health, Inc. Announces 1-for-70 Reverse Stock Split

2019-06-05 08:00:00 | Jaguar Health CEO and Board Members Invest in Bridge Financing

2019-06-03 08:00:00 | Jaguar Health Refinances $10.5 Million of Secured Debt, Including an Extension of the Maturity of Such Debt from December 31, 2019 to December 31, 2020

2019-05-29 08:00:00 | Jaguar Health Eliminates More Than $6.4 Million in Secured Promissory Notes to Strengthen Company's Balance Sheet

2019-05-24 16:15:00 | Jaguar Health, Inc. Reports Voting Results from May 24, 2019 Annual Meeting of Stockholders

2019-05-24 08:30:00 | Jaguar Health, Inc. Reports 2019 First Quarter Financial Results

2019-04-25 08:00:00 | Jaguar Health Donates Supply of Mytesi to Humanitarian Aid Organization Direct Relief

2019-04-10 09:22:00 | Jaguar Health, Inc. Reports 2018 Fourth Quarter and Year End Financial Results

2019-04-02 06:00:00 | Jaguar Health Subsidiary Napo Pharmaceuticals Issues Further Regulatory Update Regarding Potential Follow-on Indication for Mytesi

2019-04-01 08:05:00 | Jaguar Health, Pipeline Review and Progress

2019-03-28 06:00:00 | Jaguar Health Issues Regulatory Update Regarding Potential Follow-on Indication for Mytesi

2019-03-27 14:35:00 | Four Biotech Stocks Setting The Standard On Wednesday

2019-03-20 06:30:00 | Jaguar Completes Filing of CMC Technical Section with FDA for Use of Canalevia for Treatment of Chemotherapy-Induced Diarrhea in Dogs

2019-03-18 14:00:00 | Four Healthcare Stocks Heating Up On Monday

2019-03-05 09:00:00 | Jaguar Health, Inc. Reports Voting Results from February 28, 2019 Special Meeting of Stockholders

2019-02-25 12:00:00 | Jaguar Health Announces Adjournment of Special Meeting of Stockholders Until Thursday, February 28, 2019

2019-02-21 14:09:19 | What Kind Of Shareholders Own Jaguar Health, Inc. NASDAQ:JAGX?

2019-01-24 09:00:00 | With the Addition of Mytesi to the Formulary for Florida's AIDS Drug Assistance Program ADAP, Approximately 86% of ADAP-Eligible US Lives Now Have Access to Jaguar Health's FDA-Approved Drug Product

2019-01-22 09:00:00 | Jaguar Health to Present at Noble Capital Markets Annual Investor Conference January 28 in Fort Lauderdale

2019-01-09 08:00:00 | Jaguar Health Receives First Order for First-Generation of Equilevia, the Company's Non-Prescription, Personalized, Premium Product for Total Gut Health in High-Performance Equine Athletes

2019-01-07 08:00:00 | Jaguar Health Provides Fourth Quarter 2018 Commercial Sales Updates

2019-01-03 08:00:00 | Jaguar Health to Present at Biotech Showcase 2019 in San Francisco

2019-01-02 08:00:00 | Jaguar Health to Host Investor Call January 7th at 8 a.m. Eastern to Review 4Q'18 Performance

2018-12-06 08:00:00 | Jaguar Health, Inc. Engages T.R. Winston & Company to Advise on Collaboration, Licensing and Development Activities Related to Mytesi and Crofelemer

2018-11-14 20:05:00 | Jaguar Health, Inc. Reports Third-Quarter 2018 Results

2018-11-13 08:00:00 | Reminder: Jaguar Health, Inc. Will Release 3Q'18 Financial Results After Market on November 14th

2018-10-29 09:00:00 | The Brilliance Behind a Global Operator of Crypto Exchanges BitMax: Understanding the Trans-Fee Mining Model

2018-10-29 09:00:00 | Jaguar Health, Inc. Expects to File Third-Quarter 2018 Financial Results November 14th

2018-10-24 09:00:00 | Jaguar Health, Inc. to Host Investor Meetings at Dawson James Small Cap Growth Conference Tuesday, October 30, 2018 in Jupiter, Florida

2018-10-18 09:25:00 | Investor Expectations to Drive Momentum within Aethlon Medical, Jaguar Animal Health, Advaxis, Forestar Group, Platform Specialty Products, and AVEO Pharmaceuticals — Discovering Underlying Factors of Influence

2018-10-02 06:00:00 | Jaguar Health Announces Pricing of $9 Million Underwritten Public Offering

2018-09-26 10:30:00 | These Biotech and Cannabis Stocks Are Skyrocketing

2018-09-25 14:40:00 | Jaguar Health's stock triples after licensing deal, has been halted 13 times for volatility

2018-09-24 16:36:28 | Knight Therapeutics and Jaguar Health Announce Strategic Partnership

2018-09-24 16:30:00 | Knight Therapeutics and Jaguar Health Announce Strategic Partnership

2018-08-27 07:55:00 | Detailed Research: Economic Perspectives on The Michaels Companies, Glu Mobile, Natus Medical, Progenics Pharmaceuticals, QuinStreet, and Jaguar Health — What Drives Growth in Today's Competitive Landscape

2018-07-25 08:00:00 | RedHill Biopharma Initiates Co-Promotion of HIV/AIDS Anti-Diarrheal Drug Mytesi®

2018-07-24 09:00:00 | New Analysis of Data in Over 21,000 People Living with HIV Shows Diarrhea Continues to be an Issue and Has Not Declined Significantly Over Time

2018-07-18 07:20:00 | Free Daily Technical Summary Reports on Iovance Biotherapeutics and Three Other Biotech Stocks

2018-07-16 09:00:00 | Napo Pharmaceuticals to Present New Data at the 22nd International AIDS 2018 Conference

2018-07-16 08:00:00 | Today's Research Reports on Trending Tickers: Zogenix and Momenta Pharmaceuticals

2018-07-12 09:00:00 | Jaguar Health, Inc. Provides Second Quarter 2018 Financial Updates

2018-06-28 09:00:00 | RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®

2018-06-28 09:00:00 | Jaguar Health NASDAQ: JAGX Subsidiary Napo Pharmaceuticals and RedHill Biopharma Enter U.S. Co-Promotion Agreement for Mytesi, Napo's FDA-Approved Drug Product

2018-06-25 07:45:00 | Research Report Identifies Glu Mobile, Reliance Steel & Aluminum, FedEx, Jaguar Animal Health, Box, and VirnetX Holding with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2018-06-20 09:00:00 | Jaguar Health Appoints Pharmaceutical Industry Veteran David MacNaughtan to Board of Directors

2018-06-18 09:00:00 | Jaguar Health Appoints Senior Commercial Pharmaceutical Executive Greg Divis to Board of Directors

2018-06-15 07:09:00 | Iovance Biotherapeutics and Three Additional Biotech Stocks on Our Research Desk's Radar